Clinical Trial

Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria

Name: Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria — clinical trial record (NCT07680413)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RUSH

Recruiting

View on ClinicalTrials.gov →

Summary

This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.

Trial Details

NCT Number	NCT07680413
Lead Sponsor	Bharat Serums and Vaccines Limited Collaborators: Innvocept Global Solutions Private Limited
Conditions	Chronic Urticaria
Enrollment	600 participants
Start Date	2025-12-31
Primary Completion	2026-09 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-07-02